|
MechanismSCN9A gene inhibitors |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Polaris AI Pharma Corp.
0 Patents (Medical) associated with Polaris AI Pharma Corp.
100 Deals associated with Polaris AI Pharma Corp.
100 Translational Medicine associated with Polaris AI Pharma Corp.